KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for GlomerulonephritisLaurence H. Beck, Meryl Waldman, Andrew S. Bomback et al.|American Journal of Kidney Diseases|2013Cited by 239
Rationale and design of the Kidney Precision Medicine ProjectIan H. de Boer, Jonathan Himmelfarb, Pierre C. Dagher et al.|Kidney International|2021Cited by 187
Pathology after Eculizumab in Dense Deposit Disease and C3 GNLeal Herlitz, Vivette D. D’Agati, Andrew S. Bomback et al.|Journal of the American Society of Nephrology|2012Cited by 153
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, Daniel L. Bivona, David J. Friedman et al.|Nature Communications|2023Cited by 68